Physician profile
Julia Canty
NPI 1467118331
$1,040.47
in general payments reported to CMS, 2019-2025
8 companies · $480 in 2025
The $480 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $12.27 · 2023: $81.53 · 2024: $467 · 2025: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,028.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,028.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $359.44 | 2023-2025 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $308.15 | 2023-2025 | Farxiga, Breztri, Airsupra |
| Axsome Therapeutics, INC. | $124.74 | 2025 | Auvelity |
| Novo Nordisk INC | $86.10 | 2022-2025 | Ozempic, Rybelsus |
| Exact Sciences Corporation | $77.89 | 2024-2025 | Cologuard Collection Kit |
| Pfizer INC. | $42.06 | 2023-2024 | |
| Inspire Medical Systems, INC. | $25.42 | 2025 | Inspire |
| Abbvie INC. | $16.67 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Canty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.